NIH's Funding Boost to Support Grants

-
The National Institutes of Health will allow the average award value of competing grants for fiscal 2008 to increase by three percent for fiscal 2009, in line with the three percent increase the institutes received under this year's budget appropriation from Congress, NIH said this week.

NIH is predicting that this year's appropriation of $30.3 billion from the omnibus spending bill will allow its institutes and centers (ICs) to support approximately 9,800 new and competing research project grants.

The ICs are expected to maintain the average number of new investigators as it did in the five most recent years, and to continue to use the NIH Director's Innovator Awards and the NIH Pathway to Independence awards within the common fund.

The ICs also are expected to continue to use the NIH Director's Bridge Award Program, which gives continued but limited funding to meritorious investigators whose applications were close to the funding range of the relevant IC, but which have little support from elsewhere. That program will provide up to one year's funding across NIH in order to "help balance the grant cycling variation challenges and support other approaches to sustain established grantees and first time competing renewals."

NIH also said that the Ruth L. Kirschstein National Research Awards will support a one percent increase in fiscal 2009 in all stipend levels.

Related Stories


    XTractor Premium - A Platform for discovery, analysis and modelling of published biomedical facts.














Comments

Post a Comment

Popular posts from this blog

Abbott Laboratories Buys Piramal Healthcare Limited Biz for $3.72B

-
Abbott May 21 announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion , plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market. This further accelerates Abbott's emerging markets growth following the recent acquisition of Solvay Pharmaceuticals and announcements last week of Abbott's collaboration with Zydus Cadila as well as the creation of a new stand-alone Established Products Division to focus on expanding the global markets for its leading branded generics portfolio. "This strategic action will advance Abbott into the leading market position in India , one of the world's most attractive and rapidly growing markets," said Miles D. White , chairman and chief executive officer, Abbott. &quo
Read more

Top 25 Indian Bioinformatics Companies

-
Here is another, quite interesting blog page with a list of Top 25 Indian Bioinformatics Companies by a fellow blogger Nabeel Basheer, while there is no actual criteria behind listing these 25 companies. It is a good handy list just in alphabetic order for all those job seekers. More so a good chronicle of the local informatics industry as well. 1. Accelrys Software Solution Pvt Ltd. 12th Floor, Discover, ITPL, White Field, Bangalore-65. www.accelrys.com 2. Apticraft Systems (P) Ltd. 142, Electronics Complex, Pardeshipura, Indore – 452010 (M.P.), India www.apticraft.com 3. Aptuit Informatics Plot No. 100-103, Export Promotion Industrial Park, White Field, Bangalore-560066 www.aptiuit.com 4. Bigtec J. K. Towers, 8th Block, Sangam Circle,46th Cross, Bangalore-560082. www.bigtec.org 5. Bijam Biosciences Private Limited Nagarjuna Hills, Hyderabad 500 082, India www.nagarjunagroup.com 6. Bio Base Databases India Pvt Ltd. Crescent Towers, 4th Floor, No : 32/1, Crescent Road, Bnagalore -
Read more